DTL
TEVA icon

Dynamic Technology Lab’s Teva Pharmaceuticals TEVA Stock Holding History

Dynamic Technology Lab’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,715
Closed -$156K – 1322
2023
Q2 		$156K Buy
+20,715
New +$168K 0.02% 860
2022
Q3 		– Sell
-48,994
Closed -$369K – 1521
2022
Q2 		$369K Buy
+48,994
New +$427K 0.04% 698
2021
Q3 		– Sell
-34,222
Closed -$339K – 1461
2021
Q2 		$339K Buy
+34,222
New +$362K 0.03% 734
2021
Q1 		– Sell
-41,954
Closed -$405K – 1473
2020
Q4 		$405K Buy
41,954
+24,742
+144% +$237K 0.07% 536
2020
Q3 		$155K Buy
+17,212
New +$182K 0.03% 840
2020
Q2 		– Sell
-34,511
Closed -$310K – 1335
2020
Q1 		$310K Buy
+34,511
New +$354K 0.06% 569
2019
Q2 		– Sell
-60,976
Closed -$956K – 1272
2019
Q1 		$956K Buy
60,976
+40,839
+203% +$720K 0.16% 196
2018
Q4 		$310K Buy
+20,137
New +$413K 0.05% 621
2018
Q2 		– Sell
-17,128
Closed -$293K – 1310
2018
Q1 		$293K Buy
+17,128
New +$334K 0.04% 715
2016
Q4 		– Sell
-7,500
Closed -$345K – 1151
2016
Q3 		$345K Buy
7,500
+1,120
+18% +$58.4K 0.09% 423
2016
Q2 		$321K Buy
6,380
+280
+5% +$14.9K 0.09% 483
2016
Q1 		$327K Buy
+6,100
New +$358K 0.09% 480

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Dynamic Technology Lab's TEVA Position: Q3 2023 in Review

Dynamic Technology Lab sold out of Teva Pharmaceuticals (TEVA) in Q3 2023, closing a stake of 20,715 shares — an estimated $156K sold.

Dynamic Technology Lab first reported a position in TEVA in Q1 2016 and held it in 12 quarters. The position peaked at $956K in Q1 2019. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • Dynamic Technology Lab reported no remaining Teva Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 20,715 Teva Pharmaceuticals shares in Q3 2023, an estimated $156K.
  • Dynamic Technology Lab first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 12 quarters.
  • Dynamic Technology Lab's Teva Pharmaceuticals position peaked at $956K in Q1 2019.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on Dynamic Technology Lab's 13F filing for Q3 2023, filed 14 Nov 2023.